COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

CTRI KL2 Awardee Pramparo is First Author on Journal Paper

Tiziano Pramparo, PhD

Tiziano Pramparo, PhD

CTRI KL2 Scholar Tiziano Pramparo, PhD, was the first author in a paper recently published in JAMA Psychiatry. The paper is about a study in which an international team of researchers led by UC San Diego reported finding a highly accurate blood-based measure that could lead to the development of a clinical test for autism spectrum disorder risk in males as young as one to two years old. Pramparo joined principal investigator Eric Courchesne, PhD, professor of neurosciences and director of the Autism Center of Excellence (ACE) at UC San Diego, and colleagues in the study.

The paper, "Prediction of Autism by Translation and Immune/Inflammation Coexpressed Genes in Toddlers From Pediatric Community Practices," was published online March 4, 2015. 

Pramparo is an assistant research scientist in the UC San Diego Department of Neurosciences and a member of the ACE research team. He received the KL2 award from CTRI in 2012, which supported him, in part, in the study. The CTRI KL2 is an award for junior faculty that offers training and mentored research experience for up to three years. 

Read more about the study in the UC San Diego Health press release, "Blood-based Genetic Markers Identify Young Boys with Autism." 

About UC San Diego Altman Clinical and Translational Research Institute:

UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.